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Our published homology model of KCNQ1(Biochemistry 46:14141;2007)
shows that four of the residues (S140, V141, I274, A300) associated with
gain-of-function mutations come together in the open state at the interface be-
tween the voltage sensor from one subunit and the pore domain of another.
We propose that the interaction between these residues enhances the open
state, yielding the higher activity measured when these KCNQ1 mutants are
co-expressed with KCNE1. To test this hypothesis KCNQ1 V141 and I274
residues were mutated to cysteine, expressed in CHO-K1 cells and whole-
cell currents measured from 80 to þ50mV, holding potential= 80mV.
Expression of KCNQ1_V141C-I274C channels generated whole-cell currents
much larger (615590 pA) than KCNQ1_WT (240564 pA) or either
KCNQ1_V141C (277526 pA) or KCNQ1_I274C (299560 pA) channels.
Analysis of biotinylated membrane proteins showed that KCNQ1_WT and
KCNQ1_V141C-I274C express at similar levels. To test whether the larger
currents measured from cells expressing KCNQ1_V141C-I274C channels
were due to V141C and I274C forming disulfide bonds; these cells were
superfused with DTT (reducing agent) or Cu/phenanthroline (disulfide-pro-
moting agent). DTT reduced current amplitude but not Cu-phenanthroline.
DTT likely reduces current magnitude by preventing disulfide bond formation,
while Cu-phenanthroline has no effect, presumably because all potential
V141C-I274C disulfide bonds are already formed. Further evidence that
KCNQ1 residues 141 and 274 interaction favors the open state was demon-
strated by superfusion of cells expressing KCNQ1_V141C-I274C channels
with a high potassium (Kþ) bath solution. A large inward current was
measured at negative potentials indicating that the channels were constitu-
tively open. Addition of DTT to the high Kþ bath reduced the inward current
amplitude. In summary, our results strongly suggest that the interaction be-
tween residues 141 and 274 in KCNQ1 favors the open state. In addition,
these results validate the KCNQ1 model as a viable tool for structure-
function relationship studies.
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Based on sequence homology, eight Shaker-related subfamilies of voltage-
gated Kþ (Kv) channel a-subunits have been identified: Kv1-Kv6 and
Kv8-Kv9. The Kv1-Kv4 subfamilies generate functional channels in both
homo- and heterotetrameric configuration while the silent (KvS) channel
subunits (Kv5-9) do not form functional homotetramers. These KvS subunits
assemble with Kv2 subunits generating functional Kv2/KvS heterotetramers
with unique biophysical properties. The diversity within the Kv2 subfamily
is further increased by interactions with auxiliary b-subunits (e.g. AMIGO
and KCNE1) resulting in altered biophysical properties compared to
Kv2.1 alone. While Kv2.1 subunits interact with both the modulatory KvS
a-subunits and auxiliary b-subunits, it has not been investigated whether
auxiliary b-subunits also interact with Kv2/KvS heterotetramers. We
demonstrate here that the transmembrane b-subunit KCNE1 also interacts
with Kv2.1/Kv6.4 heterotetramers. Co-expression of KCNE1 with Kv2.1
and Kv6.4 shifts the voltage-dependence of activation approximately 10
mV into hyperpolarizing potentials compared to that of Kv2.1/Kv6.4 alone,
without influencing the voltage-dependence of the Kv2.1/Kv6.4 inactivation.
This Kv2.1/Kv6.4/KCNE1 interaction was confirmed by Fluorescence Reso-
nance Energy Transfer (FRET) experiments. Co-expression of N-terminal
CFP-tagged Kv6.4 with C-terminal YFP-tagged KCNE1 in HEK293 cells
did not result in FRET while co-expression of CFP-Kv6.4 with KCNE1-
YFP and unlabeled Kv2.1 yielded a FRET efficiency of 6 % which is similar
to the FRET efficiency of the positive CFP-Kv2.1 þ KCNE1-YFP combina-
tion. Furthermore, RT-PCR experiments revealed that Kv6.4 and KCNE1
subunits posses an overlapping expression pattern. These results suggest
that a triple complex consisting of Kv2.1, Kv6.4 and KCNE1 subunits can
be formed in heterologous cells and might also exist and play a function
in vivo.
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Encoded by Kv7.2/Kv7.3 subunit assembly, M-channels generate sub-
threshold voltage-gated Kþ currents that regulate neuronal excitability. In
our quest to target neuronal M-channels, we previously designed novel
diphenylamine carboxylates that are powerful Kv7.2 channel openers. These
drugs stabilize the Kv7.2 channel open state by interacting with its voltage
sensing domain (VSD). Using the same structural framework, we designed a
novel molecule, NH34, to test its activity on neuronal excitability and probe
its potency in vivo on inflammatory and neuropathic pain. In transfected
CHO cells, NH34 significantly increased Kv7.2 currents, by producing a hyper-
polarizing voltage shift of the activation curve (EC50 = 17.5 mM). Interestingly,
two S4 mutants, R198A and R207W significantly decreased the opener potency
of the drug, suggesting that NH34, like NH29, may interact with the VSD of
Kv7.2. NH34 preferentially acts as an opener of Kv7.2 and Kv7.3 channels.
NH34 was ineffective on Kv7.4 and Kv7.5 but produced a significant inhibition
of TRPV1 cation channels. In CA1 pyramidal neurons from rat hippocampal
slices, NH34 reduced the spike discharge frequency evoked by injection of de-
polarizing current. NH34 significantly depressed the slope of field epsp and the
fiber volley amplitude recorded extracellularly in the CA1 pyramidal region
following stimulation of the Schaeffer collaterals. NH34 reduced the frequency
of evoked spike discharge in dorsal root ganglion neurons. In vivo, NH34
(3-30 mg/kg p.o) significantly relieved the hyperalgesia evoked by mechanical
pressure of the paw in a rat model of inflammatory pain. Similarly, NH34 (3-30
mg/kg p.o) was very efficient in alleviating the hyperalgesia evoked by
mechanical pressure or cold allodynia in a Seltzer rat model of neuropathic
pain. In all, the data suggest that NH34 is a very promising drug template for
treating inflammatory and neuropathic pain.
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KCNQ1 associates with KCNE1 (Q1/E1) to form slow delayed rectifier (IKs)
channels, a ‘repolarization reserve’ in human ventricles. IKs activators may be
used to treat LQT syndromes. The level of E1 presence in Q1/E1 complexes
can affect the potency of IKs activators and their therapeutic efficacy. We inves-
tigate the molecular mechanisms of ‘E1-induced change in potency’ for two
experimental IKs activators: thimerosal (TMS) and ML277. TMS acts from
outside the cell membrane and requires disulfide formation with native Cys to
manifest its activator effect. TMS left shifts the half-maximum activation
voltage (V0.5) of both Q1 and Q1/E1. In oocyte expression, TMS increases the
estimated maximal current amplitude (Imax) of Q1/E1 but reduces Imax of Q1.
ML277 acts from inside the cell membrane. ML277 left shifts V0.5 and increases
Imax, with a higher potency in Q1 than Q1/E1. We identify two putative ‘drug-
binding pockets’ in our experimentally validated 3-D models of Q1 and Q1/E1:
one in the space between S3 and S4 helices accessible to the extracellular space
and right above C214 on S3, and the other between S2-S3 and S4-S5 linkers
accessible to the intracellular space. They are defined as putative TMS- and
ML277-binding sites, respectively. In silico docking shows: (a) TMS salt-
bridges with K218 when docked to Q1, but salt-bridges with R228 when docked
to Q1/E1. (b)ML277 preferentially interacts with a ring of Arg on S2-S3 and S4-
S5 linkers when docked to Q1, but aromatic stacks with a ring of Phe on S5 and
S6 when docked to Q1/E1. Mutagenesis/voltage-clamp experiments are under-
way to test these predictions, and implications in drug potency are interpreted
based on our knowledge of the structure-function relationship of IKs channel.
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Calmodulin (CaM) confers calcium-dependent regulation to a large array of
intracellular proteins, although calcium independent functions have also
